1. Home
  2. CYD vs NRIX Comparison

CYD vs NRIX Comparison

Compare CYD & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

N/A

Current Price

$40.76

Market Cap

1.7B

Sector

Industrials

ML Signal

N/A

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

N/A

Current Price

$14.72

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CYD
NRIX
Founded
1951
2009
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CYD
NRIX
Price
$40.76
$14.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
12
Target Price
$60.00
$30.58
AVG Volume (30 Days)
251.6K
785.4K
Earning Date
02-24-2026
04-07-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$15.94
N/A
Revenue Next Year
$7.89
$26.32
P/E Ratio
$32.71
N/A
Revenue Growth
N/A
99.31
52 Week Low
$12.66
$8.18
52 Week High
$56.55
$22.50

Technical Indicators

Market Signals
Indicator
CYD
NRIX
Relative Strength Index (RSI) 41.34 38.66
Support Level $40.53 $11.34
Resistance Level $41.24 $16.47
Average True Range (ATR) 1.92 0.79
MACD -0.22 -0.03
Stochastic Oscillator 48.64 30.88

Price Performance

Historical Comparison
CYD
NRIX

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: